Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/1998
12/10/1998WO1998055623A1 Type-1 ribosome-inactivating protein
12/10/1998WO1998055622A1 Preparation of glycosylated tumor necrosis factor
12/10/1998WO1998055621A1 Ntn-2 member of tnf ligand family
12/10/1998WO1998055620A1 Ntn-2 member of tnf ligand family
12/10/1998WO1998055619A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998WO1998055617A1 Translational regulator initiation factor 4e-binding protein
12/10/1998WO1998055616A2 Brca2 locus-associated protein
12/10/1998WO1998055615A1 Apaf-1, the ced-4 human homolog, an activator of caspase-3
12/10/1998WO1998055614A2 Secreted proteins and polynucleotides encoding them
12/10/1998WO1998055613A1 Zinc ring protein
12/10/1998WO1998055609A1 Inhibitors of dna immunostimulatory sequence activity
12/10/1998WO1998055606A2 Lactoferrin receptor genes of moraxella
12/10/1998WO1998055604A1 Hydrophilic composition containing protease produced by vibrio
12/10/1998WO1998055600A2 New human ribonuclease
12/10/1998WO1998055597A1 A method for culturing cells
12/10/1998WO1998055594A2 Methods for chondrocyte growth and differentiation
12/10/1998WO1998055512A2 Smad-interacting polypeptides and their use
12/10/1998WO1998055511A1 Novel canine cytokine protein
12/10/1998WO1998055510A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998WO1998055509A2 Two human dnaj-like proteins
12/10/1998WO1998055508A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS
12/10/1998WO1998055507A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998WO1998055506A2 Thrombin-inhibiting peptide
12/10/1998WO1998055505A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them
12/10/1998WO1998055504A1 HsPLA2 GR II PEPTIDES EXHIBITING AN ANTICOAGULANT EFFECT
12/10/1998WO1998055500A1 Chemically modified polypeptides
12/10/1998WO1998055495A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
12/10/1998WO1998055479A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055470A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055455A2 Modification of platelet action by fibrinogen-coated particles
12/10/1998WO1998055453A1 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
12/10/1998WO1998055449A1 Hydroxamic acid compounds having anticancer and anti-parasitic properties
12/10/1998WO1998055161A1 New medicaments based on polymers composed of methacrylamide-modified gelatin
12/10/1998WO1998055151A1 Box-dependent myc-interacting protein (bin1) compositions and uses therefor
12/10/1998WO1998055150A1 Txu-7-pap immunotoxin and use thereof
12/10/1998WO1998055145A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998WO1998055144A1 Methods for treating obesity
12/10/1998WO1998055143A1 Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
12/10/1998WO1998055142A1 Methods for treating thrombotic disorders
12/10/1998WO1998055141A1 Methods and products for inducing apoptosis in neuroendocrine cells with macrophage stimulating protein
12/10/1998WO1998055140A1 Fibrinogen concentrate from human plasma
12/10/1998WO1998055139A1 Use of leptin antagonists for the treatment of diabetes
12/10/1998WO1998055138A1 Pharmaceutical composition containing transfer factor for treatment of inflammatory bowel disease and regressive behavioural disorder
12/10/1998WO1998055137A1 Bone morphogenetic proteins and their use in bone growth
12/10/1998WO1998055136A1 Fsh-releasing peptides
12/10/1998WO1998055135A1 Protective compositions
12/10/1998WO1998055134A1 Treatment of heart failure with growth hormone
12/10/1998WO1998055132A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998WO1998055129A1 Anti-coagulation of blood, blood plasma or synovial fluid products
12/10/1998WO1998055119A1 Antagonists of gonadotropin releasing hormone
12/10/1998WO1998055110A2 NEW USES FOR COMPOUNDS WHICH REDUCE c-jun GENE EXPRESSION
12/10/1998WO1998055105A1 Fibrinogen-coated microspheres
12/10/1998WO1998055083A1 Keratin fibre oxidation dyeing composition and dyeing method using same
12/10/1998WO1998055075A2 Compositions and methods for inhibiting photoaging of skin
12/10/1998WO1998054963A2 207 human secreted proteins
12/10/1998WO1998041188A3 Stable particle in liquid formulations
12/10/1998WO1998040497A3 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
12/10/1998WO1998039465A3 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
12/10/1998WO1998036059A3 Prion propagation inhibition by dominant-negative prion protein mutants
12/10/1998WO1998033893A3 Ribozymes cleaving epidermal growth factor receptors
12/10/1998WO1998030590A3 Analogs of parathyroid hormone
12/10/1998WO1998029437A3 Mammalian equilibrative nucleoside transporters
12/10/1998DE19823351A1 Agent for inhibiting apoptosis
12/10/1998DE19724793A1 New peptides inhibit vascular endothelial cell growth factor
12/10/1998DE19724791A1 Thrombin hemmende Peptide Thrombin inhibitory peptides
12/10/1998CA2328503A1 Pharmaceutical composition containing transfer factor for treatment of inflammatory bowel disease and regressive behavioural disorder
12/10/1998CA2294494A1 Fibrinogen-coated microspheres
12/10/1998CA2293693A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998CA2293664A1 Fsh-releasing peptides
12/10/1998CA2293504A1 Use of leptin antagonists for the treatment of diabetes
12/10/1998CA2293429A1 Methods for treating thrombotic disorders
12/10/1998CA2293296A1 Human proteins having transmembrane domains and dnas encoding these proteins
12/10/1998CA2292899A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292892A1 Translational regulator initiation factor 4e-binding protein
12/10/1998CA2292891A1 Zinc ring protein
12/10/1998CA2292838A1 Lactoferrin receptor genes of moraxella
12/10/1998CA2292835A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292643A1 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998CA2292605A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2292595A1 Anti-coagulation of blood, blood plasma or synovial fluid products
12/10/1998CA2292478A1 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor
12/10/1998CA2292426A1 Txu-7-pap immunotoxin and use thereof
12/10/1998CA2291829A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2291661A1 New human ribonuclease
12/10/1998CA2291647A1 Antagonists of gonadotropin releasing hormone
12/10/1998CA2291485A1 Secreted proteins and polynucleotides encoding them
12/10/1998CA2291260A1 207 human secreted proteins
12/10/1998CA2291010A1 Herpes simplex virus vp22 vaccines and methods of use
12/10/1998CA2290806A1 New medicaments based on polymers composed of methacrylamide-modified gelatin
12/10/1998CA2290681A1 Keratin fibre oxidation dyeing composition and dyeing method using same
12/10/1998CA2289564A1 Preparation of glycosylated tumor necrosis factor
12/10/1998CA2289479A1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998CA2287848A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998CA2262463A1 New uses for compounds which reduce c-jun gene expression
12/10/1998CA2234411A1 Novel compounds
12/09/1998EP0882799A1 ANTI-HUMAN VEGF RECEPTOR F1t-1 MONOCLONAL ANTIBODY
12/09/1998EP0882796A2 Nucleic acid molecules encoding Streptococcus pneumoniae rnc protein, and compositions comprising the same
12/09/1998EP0882795A2 Recombinant secA1 polypeptides from Staphylococcus aureus and uses thereof
12/09/1998EP0882794A2 Human complementarity determining region (CDR)-grafted antibody to ganglioside gm2
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene